Targeted IL-22 Improves Glucose Tolerance and Reduces Hepatic Steatosis and Hepatic Fibrosis in Murine Models of Diabetes and Liver Disease

被引：0
|
作者：
Prins, John B.
Sajiir, Haressh
Keshvari, Sahar
Wong, Kuan Yau
Lockett, Jack
McGuckin, Michael
Hasnain, Sumaira Z.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-119-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Blocking the Hepatic Branch of the Vagus Aggravates Hepatic Ischemia-Reperfusion Injury via Inhibiting the Expression of IL-22 in the Liver
    Zhou, Heng
    Xu, Juling
    Huang, Sanxiong
    He, Ying
    He, Xiaowei
    Guo, Lu
    Yin, Shi
    Lu, Sheng
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [22] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
    Axelsson, Annika S.
    Tubbs, Emily
    Mecham, Brig
    Chacko, Shaji
    Nenonen, Hannah A.
    Tang, Yunzhao
    Fahey, Jed W.
    Derry, Jonathan M. J.
    Wollheim, Claes B.
    Wierup, Nils
    Haymond, Morey W.
    Friend, Stephen H.
    Mulder, Hindrik
    Rosengren, Anders H.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (394)
  • [23] Alterations of Hepatic Mitochondrial Respiration in Murine Models of Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD)
    Dewidar, Bedair
    Reinadofundo, Michelle
    Englisch, Cornelia
    Mastrototaro, Lucia
    Pesta, Dominik
    Ress, Claudia
    Esposito, Irene
    Roden, Michael
    DIABETES, 2021, 70
  • [24] HEPATIC STELLATE CELLS ARE THE MAJOR SOURCE OF COLLAGEN IN MURINE MODELS OF LIVER FIBROSIS
    Oesterreicher, C. H.
    Lemberger, U. J.
    Mahon, R.
    Ruelicke, T.
    Trauner, M.
    Casanova, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S61 - S61
  • [25] Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults
    Zheng, Dayang
    Liu, Xiang
    Zeng, Wei
    Zhou, Wangyan
    Zhou, Chunxiang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Mansour, Asieh
    Pourhassan, Saeed
    Gerami, Hadis
    Mohajeri-Tehrani, Mohammad Reza
    Salahshour, Marziye
    Abbasi, Ali
    Madreseh, Elham
    Sajjadi-Jazi, Sayed Mahmoud
    OBESITY SCIENCE & PRACTICE, 2024, 10 (04):
  • [27] IL-22 alleviates the fibrosis of hepatic stellate cells via the inactivation of NLRP3 inflammasome signaling
    Xing, Zhuyun
    Wu, Yayun
    Liu, Na
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [28] KBRPL2001, a Novel GPR120 Agonist, Improves Insulin Sensitivity and Glucose Tolerance and Decreases Hepatic Steatosis in Rodent Models of Type 2 Diabetes
    Anupindi, Raghuram
    Sharma, Rajiv
    Husain, Raghib
    DIABETES, 2016, 65 : A444 - A445
  • [29] EXPRESSION OF HUMAN HEPATIC GLUCOKINASE IN LIVER IMPROVES GLUCOSE-TOLERANCE IN TRANSGENIC MICE
    HARIHARAN, N
    HILLYER, D
    MOOKTHIAR, K
    ARBEENY, C
    GREGG, R
    TREOLAR, A
    DIABETES, 1995, 44 : A18 - A18
  • [30] Albumin Deficiency Reduces Hepatic Steatosis and Improves Glucose Metabolism in a Mouse Model of Diet-Induced Obesity
    Abdollahi, Afsoun
    Narayanan, Sanjeev K.
    Frankovich, Alexandra
    Lai, Yen-Chun
    Zhang, Yi
    Henderson, Gregory C.
    NUTRIENTS, 2023, 15 (09)
12345